0001645113-22-000021.txt : 20220307
0001645113-22-000021.hdr.sgml : 20220307
20220307182521
ACCESSION NUMBER: 0001645113-22-000021
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220303
FILED AS OF DATE: 20220307
DATE AS OF CHANGE: 20220307
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Weinberg Uri
CENTRAL INDEX KEY: 0001811030
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37565
FILM NUMBER: 22719708
MAIL ADDRESS:
STREET 1: NOVOCURE INC., 20 VALLEY STREAM PARKWAY
STREET 2: SUITE 300
CITY: MALVERN
STATE: PA
ZIP: 19355
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NovoCure Ltd
CENTRAL INDEX KEY: 0001645113
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: NO. 4 THE FORUM
STREET 2: GRENVILLE STREET
CITY: ST. HELIER
STATE: Y9
ZIP: JE2 4UF
BUSINESS PHONE: 44 (0)15 3475 6700
MAIL ADDRESS:
STREET 1: NO. 4 THE FORUM
STREET 2: GRENVILLE STREET
CITY: ST. HELIER
STATE: Y9
ZIP: JE2 4UF
FORMER COMPANY:
FORMER CONFORMED NAME: Novocure Ltd
DATE OF NAME CHANGE: 20150615
4
1
wf-form4_164669550591279.xml
FORM 4
X0306
4
2022-03-03
0
0001645113
NovoCure Ltd
NVCR
0001811030
Weinberg Uri
C/O NOVOCURE INC.,
20 VALLEY STREAM PARKWAY, SUITE 300
MALVERN
PA
19355
0
1
0
0
Chief Science Officer
Ordinary Shares
2022-03-03
4
A
0
17371
0
A
49186
D
Options to Buy Ordinary Shares
80.59
2022-03-03
4
A
0
30422
80.59
A
2023-03-01
2032-02-29
Ordinary Shares
30422.0
30422
D
Options to Buy Ordinary Shares
80.59
2022-03-03
4
A
0
4961
80.59
A
2023-03-01
2032-02-29
Ordinary Shares
4961.0
4961
D
Represents restricted share units that are scheduled to vest on March 1, 2023, 2024 and 2025, subject to the reporting person's continued employment through such dates.
Options to buy 30,422 ordinary shares will vest and become exercisable in equal installments on each of March 1, 2023, 2024, 2025 and 2026, subject to the reporting person's continued employment through such dates.
Options to buy 4,961 ordinary shares will vest and become exercisable in equal installments on each of March 1, 2023 and 2024, subject to the reporting person's continued employment through such dates.
By: /s/ Steven Robbins, Attorney in Fact for Uri Weinberg
2022-03-07